J. Schonhoft

发表

ILPR repeats adopt diverse G-quadruplex conformations that determine insulin binding.

S. Basu, H. Mao, Arijit Das, 2010, Biopolymers.

The endoplasmic reticulum HSP40 co‐chaperone ERdj3/DNAJB11 assembles and functions as a tetramer

Isabelle C. Noxon, G. Lander, J. Kelly, 2017, The EMBO journal.

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

S. Gregory, H. Scher, Jun Luo, 2021, Clinical Cancer Research.

Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.

M. Gonen, H. Scher, J. Luo, 2021, European journal of cancer.

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer A C

S. Steinberg, Yipeng Wang, J. Trepel, 2021 .

Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer

Jing Wang, I. Wistuba, J. Fujimoto, 2022, British journal of cancer.

Examination of the additive value of CTC biomarkers of heterogeneity (Het) and chromosomal instability to nuclear-localized (nl) AR-V7+ CTCs in prediction of poor outcomes to androgen receptor signaling inhibitor (ARSi) in metastatic castration resistant prostate cancer (mCRPC).

H. Scher, Yipeng Wang, M. Landers, 2019, Journal of Clinical Oncology.

DNA Translocation by Human Uracil DNA Glycosylase: The Case of ssDNA and Clustered Uracils

J. Stivers, J. Schonhoft, 2013 .

Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer.

N. Schultz, H. Scher, D. Solit, 2022, European urology.

Development of an immunofluorescent AR-V7 circulating tumor cell assay – A blood-based test for men with metastatic prostate cancer

David S. K. Lu, H. Scher, R. Krupa, 2020, Journal of circulating biomarkers.

Phase I/II trial of enzalutamide and mifepristone, a glucocorticoid receptor antagonist, for metastatic castration-resistant prostate cancer.

E. Heath, W. Stadler, T. Karrison, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Molecular crowding enhances facilitated diffusion of two human DNA glycosylases

J. Stivers, Meng M. Rowland, J. Schonhoft, 2015, Nucleic acids research.

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

S. Steinberg, Yipeng Wang, J. Trepel, 2020, Clinical Cancer Research.

Timing Facilitated Site Transfer of an Enzyme on DNA

J. Stivers, J. Schonhoft, 2011, Nature chemical biology.

DNA translocation by human uracil DNA glycosylase: the case of single-stranded DNA and clustered uracils.

J. Stivers, J. Schonhoft, 2013, Biochemistry.

Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

J. Eshleman, C. Drake, Jun Luo, 2021, The Prostate.

Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer

M. Gonen, H. Scher, Yipeng Wang, 2020, Cancer Research.

CTC counts as a biomarker of prognosis and response in metastatic castration-resistant prostate cancer (mCRPC) from the CARD trial.

J. Bono, B. Tombal, C. Sternberg, 2021 .

An RNA G-quadruplex is essential for cap-independent translation initiation in human VEGF IRES.

S. Basu, Mark J. Morris, Y. Negishi, 2010, Journal of the American Chemical Society.

Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer

Jing Wang, I. Wistuba, J. Fujimoto, 2022, British Journal of Cancer.

Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer

M. Harrison, H. Scher, Jun Luo, 2020, JCO precision oncology.

Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate Cancer.

S. Tomlins, T. Morgan, F. Feng, 2019, JCO precision oncology.

ILPR G-quadruplexes formed in seconds demonstrate high mechanical stabilities.

S. Basu, H. Mao, Soma Dhakal, 2009, Journal of the American Chemical Society.

Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients

B. Cravatt, J. Kelly, Yvonne S. Eisele, 2017, Science Translational Medicine.

DISSECTING THE SEARCH PATHWAY OF DNA GLYCOSYLASES

J. Schonhoft, 2014 .

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis

H. Beltran, J. Mosquera, Yipeng Wang, 2021, npj Precision Oncology.

Microscopic mechanism of DNA damage searching by hOGG1

J. Stivers, S. David, Meng M. Rowland, 2014, Nucleic acids research.

DNA translocation by human uracil DNA glycosylase: role of DNA phosphate charge.

J. Stivers, John G. Kosowicz, J. Schonhoft, 2013, Biochemistry.

Direct experimental evidence for quadruplex–quadruplex interaction within the human ILPR

Zhongbo Yu, Soumitra Basu, Soma Dhakal, 2009, Nucleic acids research.

Biochemical and Biophysical Study of the Polymorphic G-Quadruplexes Formed by the Insulin Linked Polymorphic Region

J. Schonhoft, 2009 .

Coexistence of an ILPR i-motif and a partially folded structure with comparable mechanical stability revealed at the single-molecule level.

S. Basu, H. Mao, D. Koirala, 2010, Journal of the American Chemical Society.

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

J. Reis-Filho, R. Plummer, F. Meric-Bernstam, 2023, Nature Medicine.

Abstract CT030: Genomic and pathologic determinants of response to RP-3500, an ataxia telangiectasia and Rad3-related inhibitor (ATRi), in patients (pts) with DNA damage repair (DDR) loss-of-function (LOF) mutant tumors in the Phase 1/2 TRESR trial

J. Reis-Filho, R. Plummer, S. Lheureux, 2022, Cancer Research.

Disordered N-Terminal Domain of Human Uracil DNA Glycosylase (hUNG2) Enhances DNA Translocation.

P. Cole, J. Stivers, Alexandre Esadze, 2017, ACS chemical biology.

Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

H. Scher, Jun Luo, E. Antonarakis, 2020 .

Identification and Characterization of Circulating Tumor Cells in Men Who Have Undergone Prostatectomy for Clinically Localized, High - Risk Prostate Cancer.

M. Cooperberg, P. Carroll, Yipeng Wang, 2019, The Journal of urology.

Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)

A. Wyatt, M. Lacouture, E. Antonarakis, 2023, British journal of cancer.

ILPR G-quadruplexes formed in seconds demonstrate high mechanical stabilities.

S. Basu, H. Mao, Soma Dhakal, 2009, Journal of the American Chemical Society.